Can natriuretic peptides be used for the diagnosis of diastolic heart failure?

80Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Many patients with heart failure have stiff hearts with an increased wall thickness and small volumes leading to diastolic dysfunction. Different definitions for diastolic heart failure have been proposed but today there is no generally accepted definition and there are few large controlled studies telling us how it should be managed. Natriuretic peptides (BNP or NT-proBNP) might be used to detect patients with diastolic dysfunction especially in those patients having a restrictive filling pattern or pseudo-normalised mitral flow pattern and in those, who are symptomatic. However, patients with relaxation abnormalities and mild symptoms or asymptomatic may have normal levels of the natriuretic peptides indicating no or only slight elevation of the left ventricular filling pressures. Thus low levels cannot be used as a rule out diagnosis of diastolic dysfunction. © 2004 Published by Elsevier B.V. on behalf of European Society of Cardiology.

Cite

CITATION STYLE

APA

Dahlström, U. (2004, March 15). Can natriuretic peptides be used for the diagnosis of diastolic heart failure? European Journal of Heart Failure. https://doi.org/10.1016/j.ejheart.2004.01.005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free